Product Recalls in Wyoming

Product recalls affecting Wyoming — including food, drugs, consumer products, medical devices, and vehicles distributed to Wyoming. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,540 recalls have been distributed to Wyoming in the last 12 months.

48,219 total recalls
2,540 in last 12 months

Showing 62816300 of 13,375 recalls

DrugSeptember 21, 2018· Teva Pharmaceuticals USA

Recalled Item: Clozapine Orally Disintegrating Tablets Recalled by Teva Pharmaceuticals USA...

The Issue: Failed Disintegration Specifications: Out-of-specification disintegration...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 20, 2018· Pfizer Inc.

Recalled Item: Meropenem for Injection Recalled by Pfizer Inc. Due to Lack of assurance of...

The Issue: Lack of assurance of sterility: loss of container integrity.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 20, 2018· Pfizer Inc.

Recalled Item: Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle...

The Issue: CGMP Deviations; rejected product was used to manufacture final bulk lot

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 19, 2018· Pfizer Inc.

Recalled Item: Elelyso (taliglucerase alfa) for injection Recalled by Pfizer Inc. Due to...

The Issue: Lack of assurance of sterility -Reports of loose metal ferrule crimps on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 19, 2018· Upsher Smith Laboratories, Inc.

Recalled Item: Bumetanide Tablets Recalled by Upsher Smith Laboratories, Inc. Due to Failed...

The Issue: Failed impurities/ degradation specifications: Product is Out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 19, 2018· Upsher Smith Laboratories, Inc.

Recalled Item: Bumetanide Tablets Recalled by Upsher Smith Laboratories, Inc. Due to Failed...

The Issue: Failed impurities/ degradation specifications: Product is Out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 18, 2018· Xiromed LLC

Recalled Item: Altavera Levonorgestrel and Ethinyl Estradiol Tablets Recalled by Xiromed...

The Issue: Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 17, 2018· Otsuka Pharmaceutical Development & Commercialization, Inc.

Recalled Item: treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for...

The Issue: Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 17, 2018· Endo Pharmaceuticals, Inc.

Recalled Item: robaxin-750 (methocarbamol tablets Recalled by Endo Pharmaceuticals, Inc....

The Issue: Labeling: Incorrect Instructions: Dosage information on the immediate...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugSeptember 17, 2018· Medline Industries Inc

Recalled Item: SparkleFresh Fluoride Toothpaste Recalled by Medline Industries Inc Due to...

The Issue: Microbial Contamination of Non-Sterile Product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 17, 2018· Otsuka Pharmaceutical Development & Commercialization, Inc.

Recalled Item: treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG...

The Issue: Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 11, 2018· Torrent Pharma Inc.

Recalled Item: Lamotrigine Extended-Release Tablets Recalled by Torrent Pharma Inc. Due to...

The Issue: Failed Dissolution Specifications: Out of Specification for Dissolution test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: HCG Reconstitued 6000 IU Injectable Recalled by Pharm D Solutions, LLC Due...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: Acetylcysteine Injection 10 mg/5 mL (2 mg/mL) Recalled by Pharm D Solutions,...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: HCG Lyopholized 1200 IU Injectable Recalled by Pharm D Solutions, LLC Due to...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/20 mcg Powder Pharm D...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: Sermorelin/GHRP-2 18 mg/6 mg powder Recalled by Pharm D Solutions, LLC Due...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 10, 2018· Pharm D Solutions, LLC

Recalled Item: Bi-Mix Injection Recalled by Pharm D Solutions, LLC Due to Lack of Assurance...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund